CN205541522U - Blood vessel interventional therapy simulation equipment - Google Patents

Blood vessel interventional therapy simulation equipment Download PDF

Info

Publication number
CN205541522U
CN205541522U CN201521133766.3U CN201521133766U CN205541522U CN 205541522 U CN205541522 U CN 205541522U CN 201521133766 U CN201521133766 U CN 201521133766U CN 205541522 U CN205541522 U CN 205541522U
Authority
CN
China
Prior art keywords
support
blood vessel
utility
model
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201521133766.3U
Other languages
Chinese (zh)
Inventor
蔡志明
牟丽莎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Second Peoples Hospital
Original Assignee
Shenzhen Second Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Second Peoples Hospital filed Critical Shenzhen Second Peoples Hospital
Priority to CN201521133766.3U priority Critical patent/CN205541522U/en
Application granted granted Critical
Publication of CN205541522U publication Critical patent/CN205541522U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The utility model provides a blood vessel interventional therapy simulation equipment, including the support, every even connecting hole is arranged to the inside a plurality of that is provided with of support, and per two be provided with a plurality of evenly distributed's elasticity steelframe between the support, the support both ends are provided with the support piece of arc structure, stent sidewall is provided with semi -circular structure's medicine tank. The utility model discloses a be used for a simulation of blood vessel treatment, adaptation median size or trunk do not receive the influence of limit nature, shift in the blood vessel sureness, degree and the collateral branch blood supply circumstances and narrow on the hemodynamics such as blood pressure of below change the back, can not change into the sacculus pipe by the radiography pipe, protecting film that this equipment surface set up can be fine the protection its with hematal contact, protected the blood vessel, also protected vascular intervention equipment, place the sacculus in narrow district, when the blood flow flows past its inside honeycomb duct, can make to support slowly to strut, guaranteed the noncongestion of blood flow and stable, life is of a specified duration.

Description

Vascular interventional treatment simulator
Technical field
This utility model relates to a kind of vascular treatment equipment, specially vascular interventional treatment simulator.
Background technology
Endovascular temporary embolization is application selectivity or subselective angiographic technique, first after clear and definite pathological changes presentation, character, scope and degree, according to indication, carries out the treatments such as thromboembolism, Endovascular angioplasty and dabbling drug through inserting endovascular conduit.The disease of internal blood vessel the most multiple, scattered short section narrow and inaccessible.Long section is narrow or inaccessible, Small vessel, the narrow or Occlusion of exedens narrow or existing calcification are unsuitable for treatment, the contrast agent balloon inflation diluted with compression pump or hand push.The sacculus of inflation acts on narrow blood vessel, is allowed to expand.After expansion terminates, angiography to be checked, understand vasodilation situation, again measure the blood pressure difference of former stenosis area upper and lower to determine the effect of dilation therapy simultaneously.In order to reduce complication and prevention of restenosis, from preoperative daystart application medicament for resisting platelet aggregation, such as aspirin etc..Anticoagulant heparin to be used in art, the medicine such as postoperative 1~6 months Aspirins, persantins.Due to internal fibrinolysis activity, after thrombus obstruction blood vessel, many beginning at several hours is dissolved.The advantage of clot is to draw materials conveniently, and no antigen is not required to sterilization, and The book of Changes conduit injects, and is used for control hemorrhage compared with small artery, and inaccessible vascular time is from several thoughtful some months.Gelfoam can be sterilized, no antigen, can make different size of granule or little bar on demand, be easy to get, inexpensive, is widely used in thromboembolism, thin vessels, as hemorrhage in occlusion of bone tumors, vascular conditions and control etc..It is therefore proposed that the vascular interventional treatment simulator that service life is long.
Utility model content
The technical problems to be solved in the utility model is to overcome existing defect, it is provided that vascular interventional treatment simulator.
In order to solve above-mentioned technical problem, this utility model provides following technical scheme:
This utility model provides vascular interventional treatment simulator, and including support, each described internal stent is provided with several connecting holes arranged in a uniform, and is provided with several equally distributed elastic steelframes described in each two between support;Described support two ends are provided with the support member of arcuate structure, and described rack side wall is provided with the drug reservoir of semicircular structure.
As a kind of optimal technical scheme of the present utility model, described rack outer surface is coated with protecting film, and described protecting film is internally provided with the vesicle being connected to described support one end.
As a kind of optimal technical scheme of the present utility model, the middle part of described vesicle and described protecting film is provided with flow-guiding mouth, and described flow-guiding mouth one end is connected to mozzle.
As a kind of optimal technical scheme of the present utility model, described mozzle one end is provided with pressure-reducing ring, and described mozzle is internally provided with the slide bar that one end is connected with described flow-guiding mouth, and described slide bar surface is provided with control.
As a kind of optimal technical scheme of the present utility model, described control surface configuration has several inner frames being connected with described mozzle tube wall, and described inner frame surface configuration has several equally distributed metering holes.
This utility model is reached to provide the benefit that:
This utility model is a kind of simulation for vascular treatment, adapts to median size or big blood vessel, is not affected by limiting;After the hemodynamic changes such as the blood pressure determining displacement, degree and Branch blood feed situation and narrow upper and lower at blood vessel, foley's tube will not be exchanged into by angiography catheter;The protecting film that this equipment surface is arranged can be good at protecting its contacting with blood vessel; protect blood vessel; also blood vessel intervening equipment is protected; sacculus is placed in stenosis area; when blood flow flows through the mozzle of its inside; can make to support slowly to strut, it is ensured that blood flow unimpeded and stable, service life is long; inside drug reservoir; can place the medicine needing to treat internal blood vessel, medicine can dissolve in internal blood vessel, enters inside blood; reach therapeutic effect; the therapeutic effect of this equipment is good, and compact conformation is unlikely to deform.
Accompanying drawing explanation
Accompanying drawing is used for providing being further appreciated by of the present utility model, and constitutes a part for description, is used for explaining this utility model, is not intended that restriction of the present utility model together with embodiment of the present utility model.
In the accompanying drawings:
Fig. 1 is overall structure schematic diagram of the present utility model;
Fig. 2 is mozzle internal structure schematic diagram of the present utility model;
Label in figure: 1, elastic steelframe;2, connecting hole;3, support;4, pressure-reducing ring;5, flow-guiding mouth;6, protecting film;7, drug reservoir;8, vesicle;9, support member;10, mozzle;11, slide bar;12, control;13, metering hole;14, inner frame.
Detailed description of the invention
Below in conjunction with accompanying drawing, preferred embodiment of the present utility model is illustrated, it will be appreciated that preferred embodiment described herein is merely to illustrate and explains this utility model, be not used to limit this utility model.
Embodiment: as shown in Figure 1-2, this utility model provides vascular interventional treatment simulator, including support 3, each described support 3 is internally provided with several connecting holes 2 arranged in a uniform, and is provided with several equally distributed elastic steelframes 1 described in each two between support 3;Described support 3 two ends are provided with the support member 9 of arcuate structure, and described support 3 sidewall is provided with the drug reservoir 7 of semicircular structure.
Described support 3 outer surface is coated with protecting film 6, and described protecting film 6 is internally provided with the vesicle 8 being connected to described support 3 one end;The middle part of described vesicle 8 and described protecting film 6 is provided with flow-guiding mouth 5, and described flow-guiding mouth 5 one end is connected to mozzle 10;Described mozzle 10 one end is provided with pressure-reducing ring 4, and described mozzle 10 is internally provided with the slide bar 11 that one end is connected with described flow-guiding mouth 5, and described slide bar 11 surface is provided with control 12;Described control 12 surface configuration has several inner frames 14 being connected with described mozzle 10 tube wall, and described inner frame 14 surface configuration has several equally distributed metering holes 13.
In use, vessel support device is to use special alloy to this utility model, makes the cylindrical shape of different structure, is supported in angiostenosis lesion, is allowed to keep blood flow unobstructed.Hot memorial alloy eyelid retractor and making from swollen eyelid retractor;It is woven into cylindrical shape with stainless steel alloy silk, after putting into blood vessel, is supported in Endovascular due to metal elastic force.Bracing frame is coghill net eye-shaped, first on sacculus, puts into balloon inflation after blood vessel, makes eyelid retractor open and be supported in Endovascular.After bracing frame is placed in blood vessel, body is resistant to, and foreign reacts.In bracing frame, performance covers due to Fibrinogen, can form new intima soon, connect with the normal blood vessels inner membrance at eyelid retractor two ends, thus ensure the unobstructed of blood vessel.The application that match such as the main same balloon angioplasty of eyelid retractor, laser angioplasty and rotary-cut method.Place bracing frame, vessel open rate can be improved, reduce restenosis.The internal medicine placed of drug reservoir can selective arterial perfusion chemotherapy Drug therapy, the drug level of tumor by local can be increased, extend tumor cell with the time of contact of high concentration medicine, alleviate the whole body toxicity of medicine, the effect of chemotherapy can be improved.
Last it is noted that the foregoing is only preferred embodiment of the present utility model, it is not limited to this utility model, although this utility model being described in detail with reference to previous embodiment, for a person skilled in the art, technical scheme described in foregoing embodiments still can be modified by it, or wherein portion of techniques feature is carried out equivalent.All within spirit of the present utility model and principle, any modification, equivalent substitution and improvement etc. made, within should be included in protection domain of the present utility model.

Claims (5)

1. vascular interventional treatment simulator, including support (3), it is characterized in that, each described support (3) is internally provided with between several connecting holes arranged in a uniform (2), and support described in each two (3) and is provided with several equally distributed elastic steelframes (1);Described support (3) two ends are provided with the support member (9) of arcuate structure, and described support (3) sidewall is provided with the drug reservoir (7) of semicircular structure.
Vascular interventional treatment simulator the most according to claim 1, it is characterized in that, described support (3) outer surface is coated with protecting film (6), and described protecting film (6) is internally provided with the vesicle (8) being connected to described support (3) one end.
Vascular interventional treatment simulator the most according to claim 2, it is characterized in that, the middle part of described vesicle (8) and described protecting film (6) is provided with flow-guiding mouth (5), and described flow-guiding mouth (5) one end is connected to mozzle (10).
Vascular interventional treatment simulator the most according to claim 3, it is characterized in that, described mozzle (10) one end is provided with pressure-reducing ring (4), described mozzle (10) is internally provided with the slide bar (11) that one end is connected with described flow-guiding mouth (5), and described slide bar (11) surface is provided with control (12).
Vascular interventional treatment simulator the most according to claim 4, it is characterized in that, described control (12) surface configuration has several inner frames (14) being connected with described mozzle (10) tube wall, and described inner frame (14) surface configuration has several equally distributed metering holes (13).
CN201521133766.3U 2015-12-31 2015-12-31 Blood vessel interventional therapy simulation equipment Expired - Fee Related CN205541522U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201521133766.3U CN205541522U (en) 2015-12-31 2015-12-31 Blood vessel interventional therapy simulation equipment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201521133766.3U CN205541522U (en) 2015-12-31 2015-12-31 Blood vessel interventional therapy simulation equipment

Publications (1)

Publication Number Publication Date
CN205541522U true CN205541522U (en) 2016-08-31

Family

ID=56762263

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201521133766.3U Expired - Fee Related CN205541522U (en) 2015-12-31 2015-12-31 Blood vessel interventional therapy simulation equipment

Country Status (1)

Country Link
CN (1) CN205541522U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108498208A (en) * 2018-04-02 2018-09-07 中国人民解放军第四军医大学 Suitable for arterial vascular intravascular stent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108498208A (en) * 2018-04-02 2018-09-07 中国人民解放军第四军医大学 Suitable for arterial vascular intravascular stent
CN108498208B (en) * 2018-04-02 2021-07-09 中国人民解放军第四军医大学 Blood vessel support suitable for artery blood vessel

Similar Documents

Publication Publication Date Title
US20150018597A1 (en) Kit and devices for organ perfusion
JP5474190B2 (en) Flash catheter with flow-oriented sheath
JP6212031B2 (en) Variable length catheter for drug delivery
Griessenauer et al. Pipeline Embolization Device for small paraophthalmic artery aneurysms with an emphasis on the anatomical relationship of ophthalmic artery origin and aneurysm
CN106994204A (en) Double sacculus medicine-coated balloon dilating catheters
Nassar Endovascular management of the “failing to mature” arteriovenous fistula
CN205541522U (en) Blood vessel interventional therapy simulation equipment
US20080091140A1 (en) Cardiac Reperfusion Methods and Devices
Zuckerman et al. Novel technologies in the treatment of intracranial aneurysms
Nikam et al. Arteriovenous fistula failure: is there a role for accessory draining vein embolization?
Zander et al. Endoluminal occlusion devices: technology update
Venczelova et al. First experience with AndraStent XL implantation in children and adolescents with congenital heart diseases
CN101268971B (en) Internally bare bracket of vascellum
CN208851723U (en) The dedicated auxiliary stand of aneurysm liquid embolizing agent
Bosman et al. Treatment of types II–IV endoleaks by injecting biocompatible elastomer (PDMS) in the aneurysm sac: an in vitro study
CN204600789U (en) A kind of novel medicine carrying intravascular stent
Chand et al. Essential Interventional Radiology Review: A Question and Answer Guide
Kenny et al. Transcatheter occlusion of a classical BT shunt with the Amplatzer Duct Occluder II
CN201208318Y (en) Blood vessel internal naked stent
Todd et al. Pre-clinical investigation of liquid sirolimus for local drug delivery
CN104758023B (en) A kind of blood flow turning rack
Rana et al. Dialysis Access
Zhou et al. Healing process after flow diverting device treatment of cerebral aneurysms: current research and clinical progress
CN106491252B (en) Coronary ostium support Precise Position System
Takashima et al. Restoration of Autologous Arteriovenous Fistula by Removal of the Occluded Short Venous Part and Venovenous End-To-End Anastomosis in a Hemodialysis Patient

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160831

Termination date: 20171231